Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.30 – $0.37
99% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.5M | $20.9M | $22.5M | $25.3M | $21.9M | $32.3M | $33.1M | $39.1M |
| Cost of revenue | $5.1M | $6.7M | $8.8M | $8.6M | $25.0M | $34.9M | $8.8M | $9.6M |
| Gross profit | $12.4M | $14.2M | $13.7M | $16.7M | −$3.1M | −$2.5M | $24.4M | $29.4M |
| Gross margin | 70.8% | 67.9% | 61.0% | 66.0% | -13.9% | -7.8% | 73.5% | 75.3% |
| R&D | $359.0K | $510.0K | $396.0K | $5.1M | $220.0K | $236.0K | $313.0K | $271.0K |
| Operating income | $2.1M | $3.2M | $1.9M | −$5.2M | −$15.7M | −$14.4M | −$11.0M | $3.1M |
| EBITDA | $2.2M | $3.9M | $3.0M | −$13.4M | −$12.9M | −$4.3M | −$29.4M | $1.7M |
| Net income | $243.0K | $1.0M | $379.0K | −$12.6M | −$12.4M | −$5.6M | −$41.0M | $94.0K |
| Net margin | 1.4% | 5.0% | 1.7% | -49.7% | -56.5% | -17.3% | -123.7% | 0.2% |
| EPS (diluted) | 0.00 | 0.02 | 0.01 | -0.18 | -0.17 | -0.07 | -0.47 | 0.00 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $43M | $-0.01 | $-0.01–$-0.01 | 1 |
| 2027 | $47M | $0.01 | $0.01–$0.01 | 1 |
| 2028 | $53M | $0.03 | $0.03–$0.03 | 1 |
| 2029 | $59M | $0.09 | $0.09–$0.09 | 1 |
Forward consensus · source: Financial Modeling Prep
MEDICAL DEV INTL LTD ORD
No one on the platform currently holds MDDVF.
No tracked institution reports a position in MDDVF as of their last filing.
No one on the platform has traded MDDVF yet.
| $378874 |
| — |
| GHBWFGlass House Brands Inc Warrant 2021-29.06.26 on Glass House Brd | $0.13 | +8.33% | $11M | — |
| ITHUFiAnthus Capital Holdings, Inc. | $0.01 | +12.36% | $35M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.5× sales vs its 1.6× historical median P/S.
Fair value ≈ $1.28 · price $0.37 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.